Bharat Book Bureau Provides the Trending Industry Research Report on“Oncolytic Virus Immunotherapy Market – Global Outlook and Forecast 2022-2028”under Life Sciences Market Research Report. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports.
Executive Summary
Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
This report contains market size and forecasts of Oncolytic Virus Immunotherapy in Global, including the following market information:
Global Oncolytic Virus Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oncolytic Virus Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Engineering Oncolytic Viruses Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncolytic Virus Immunotherapy include Merck, Amgen, TILT Biotherapeutics, Oncorus, Sorrento Therapeutics and Shanghai Sunway Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncolytic Virus Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncolytic Virus Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, by Type, 2021 (%)
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Global Oncolytic Virus Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Global Oncolytic Virus Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oncolytic Virus Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncolytic Virus Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oncolytic Virus Immunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Browse our full report with Table of Content : https://www.bharatbook.com/report/1309308/oncolytic-virus-immunotherapy-market-global-outlook-and-forecast
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes latest Industry Study, Industry Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
